Epilepsy and driving
AbstractEpilepsy poses a risk for all participants in road traffic; therefore people with epilepsy do not meet the criteria for an unlimited driving license. Their driving is affected not only by epileptic seizures causing impaired consciousness and involuntary movements, but also by antiepileptic drugs with their many unwanted affects. The experts have not yet agreed on whether people with epilepsy have an increased risk of experiencing a road traffic accident. However, recent data suggests that the overall risk is lower compared to other medical conditions. Scientific evidence forms the basis of legislation, which by limiting people with epilepsy, enables all participants in road traffic to drive in the safest possible environment. The legislation that governs epilepsy and driving in Slovenia has been recently thoroughly reformed and thus allows a less discriminatory management of people with epilepsy. Although people with epilepsy experience many issues in their daily life, including their personal relationships and employment, they often list the need for driving as a top concern in surveys. General physicians play an important role in managing the issues of people with epilepsy.
Brodie MJ, Schachter SC, Kwan P. Fast Facts: Epilepsy. 3rd ed. Oxford: Health Press; 2005.
Sander JW, Shorvon SD. Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry. 1996; 61(5): 433–43.
Bon J, Koritnik B, Bresjanac M, Repovš G, Pregelj P, Dobnik B, et al. Stroški možganskih bolezni v Sloveniji v letu 2010. Zdrav Vestn. 2013; 82: 164–75.
Stern JM. Overview of evaluation and treatment guidelines for epilepsy. Curr Treat Options Neurol. 2009; 11(4): 273–84.
Brouwer WH. Attention and driving: a cognitive neuropsychological approach. In: Leclercq M, Zimmermann P, ed. Applied Neuropsychology of Attention: Theory, Diagnosis and Rehabilitation. London: Psychology Press; 2002. p. 230–55.
Winston GP, Jaiser SR. Western driving regulations for unprovoked first seizures and epilepsy. Seizure. 2012; 21(5): 371–6.
Bilban M. Epilepsy and driving capability in Slovenia. Seizure. 2008; 17(5): 465–8.
Gilliam F, Kuzniecky R, Faught E, Black L, Carpenter G, Schrodt R. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia. 1997; 38(2): 233–6.
Drazkowski JF. Driving and Flying with Epilepsy. Curr Neurol Neurosci Rep. 2007; 7: 329–34.
Sonnen AE. Epilepsy and driving: a European view. Driving Commission, IBE. 1997: 11–32.
Grošelj J. Epilepsija in vozniška zmožnost. In: Zupan A, Bilban M, eds. Ocenjevanje sposobnosti za vožnjo avtomobila: zbornik predavanj; 2014 Feb 14.–15.; Ljubljana, Slovenija. Ljubljana: Univerzitetni rehabilitacijski inštitut RS – Soča, Zavod za varstvo pri delu; 2014. p. 191–9.
Drazkowski J. An overview of epilepsy and driving. Epilepsia. 2007; 48 suppl 9: 10–2.
Krumholz A. Driving and epilepsy: a historical perspective and review of current regulations. Epilepsia. 1994; 35: 696–705.
Lossius R, Kinge E, Nakken KO. Epilepsy and driving: considerations on how eligiblity should be decided. Acta Neurol Scand. 2010; 122: 67–71.
Classen S, Crizzle AM, Winter SM, Silver W, Eisenschenk S. Evidence-based review on epilepsy and driving. Epilepsy Behav. 2012; 23(2): 103–12.
Devlin AL, Odell M, Charlton JL, Koppel S. Epilepsy and driving: currrent status of research. Epilepsy Res. 2012; 102(3): 135–52.
Bielen I, Hajnšek S, Krmpotić P, Petelin Z, Sušak R, Sepić-Grahovac D, et al. Impact of partial liberalization of driver's license regulations on the driving behaviour of people with epilepsy: experience from Croatia. Epilepsy Behav. 2011; 21(4): 459–61.
Gastaut H, Zifkin BG. The risk of automobile accidents with seizures occurring while driving: relation to seizure type. Neurology. 1987; 37(10): 1613–6.
Hansotia P, Broste SK. The effect of epilepsy or diabetes mellitus on the risk of automobile accidents. N Engl J Med. 1991; 324(1): 22–6.
Krumholz A, Fisher RS, Lesser RP, Hauser WA. Driving and epilepsy. A review and reappraisal. JAMA. 1991; 265(5): 622–6.
Yale SH, Hansotia P, Knapp D, Ehrfurth J. Neurologic conditions: assessing medical fitness to drive. Clin Med Res. 2003; 1(3): 177–88.
Chadwick D. Risk of seizure recurrence in epilepsy after various seizure-free periods. In: Valmain J, Darde JB, Gappmaier B, et al, eds. Epilepsy and Driving in Europe: Brussels: Driving Licence Committee of the European Union; 2013. p. 43–9.
Fattouch J, Di Bonaventura C, Lapenta L, Casciato S, Fanella M, Morano A, et al. Epilepsy, unawareness of seizures and driving license: the potential role of 24-hour ambulatory EEG in defining seizure freedom. Epilepsy Behav. 2012; 25(1): 32–5.
Valmain J, Darde JB, Gappmaier B, Kirker J, Kraemer G, Markschies N, et al. Epilepsy and Driving in Europe: A report of the second european working group on epilepsy and driving. European Commission. Dosegljivo 5. 2. 2014 s spletne strani: http://ec.europa.eu/transport/road_safety/pdf/behavior/epilepsy_and_driving_in_europe_final_report_v2_en.pdf
Vaa T. Impairment, diseases, age and their relative risk of accidents involvement: results from meta-analysis. TØI Institute of transport economics, Norwegian centre for transport research. Dosegljivo 8. 2. 2014 s spletne strani: http://www.toi.no/getfile.php/Publikasjoner/T%C3%98I%20rapporter/2003/690-2003/690-2003-el.pdf
Sheth SG, Krauss G, Krumholz A, Li G. Mortality in epilepsy: driving fatalities vs other causes of death in patients with epilepsy. Neurology. 2004; 63(6): 1002–7.
Drazkowski JF, Fisher RS, Sirven JI, Demaerschalk BM, Uber-Zak L, Hentz JG, et al. Seizure-related motor vehicle crashes in Arizona before and after reducing the driving restriction from 12 to 3 months. Mayo Clin Proc. 2003; 78(7): 819–25.
Register zdravil Republike Slovenije XII. Ljubljana: Ministrstvo za zdravstvo, Agencija RS za zdravila in medicinske pripomočke, Inštitut za varovanje zdravja Republike Slovenije; 2010.
Janko M. Zdravljenje epilepsije z antiepileptiki. Medicinski razgledi. 1990; 3: 331–45.
Silver W, Classen S, Winter S, Eisenschenk S. Effects of antiepileptic medication dosage on simulated driving performance. AES 65 Annual Meeting; 2011 december 2.-6.; Baltimore, ZDA. Epilepsy Curr. 2012; 12(1 Suppl 1): s167.
Faught E, Duh MS, Weiner JR, Guerin A, Cunnington MC. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology. 2008; 71(20): 1572–8.
Bonnett LJ, Shukralla A, Tudur-Smith C, Williamson PR, Marson AG. Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC Antiepileptic Drug Withdrawal Study and a systematic review. J Neurol Neurosurg Psychiatry. 2011; 82(12): 1328–33.
Polychronopoulus P, Argyriou AA, Huliara V, Sirrou V, Gourzis P, Chroni E. Factors associated with poor compliance of patients with epilepsy driving restrictions. Neurology. 2006; 67(5): 869–71.
Ooi WW, Gutrecht JA. International regulations for automobile driving and epilepsy. J Travel Med. 2000; 7(1): 1–4.
Bauer J, Neumann M. Fahreignung und Fahrsicherheit bei Epilepsie: Grundlagen, neue Leitlinien und Kommentar. Nervenarzt. 2009; 80: 1480–8.
Crizzle AM, Classen S, Winter SM, Silver W, LaFranca C, Eisenschenk S. Associations between clinical tests and simulated driving performance in persons with epilepsy. Epilepsy Behav. 2012; 23: 241–6.
Krauss GL, Ampaw L, Krumholz A. Individual state driving restrictions for people with epilepsy in the US. Neurology. 2001; 57: 1780–5.
Krauss GL, Krumholz A, Carter RC, Li G, Kaplan P. Risk factors for seizure-related motor vehicle crashes in patients with epilepsy. Neurology. 1999; 52(7): 1324–9.
Beran RG, Ainley LAE, Beran ME. Opinions, attitudes and practices of Australian neurologists with regard to epilepsy and driving. Intern Med J. 2007; 37: 251–7.
Epilepsy Ireland: New Irish Driving Regulations December 2010. Epilepsy Ireland. Dosegljivo 15. 3. 2014 s spletne strani: http://www.epilepsy.ie/assets/66/46F66B4D-CB58-4CA5-37B627EA4876DEC3_document/DRIVING_REGULATIONS_2010.pdf
Krumholz A. Driving issues in epilepsy: Past, present, and future. Epilepsy Curr. 2009; 9(2): 31–5.
Drazkowski JF, Neiman ES, Sirven JI, McAbee GN, Noe KH. Frequency of physician counseling and attitudes toward driving motor vehicles in people with epilepsy: comparing a mandatory-reporting with voluntary-reporting state. Epilepsy Behav. 2010; 19(1): 52–4.
Elliott JO, Long L. Perceived risks, resources, and perceptions concerning driving and epilepsy: a patient perspective. Epilepsy Behav. 2008; 13(2): 381–6.
Tatum WO, Worley AV, Selenica ML. Disobedience and driving in patients with epilepsy. Epilepsy Behav. 2012; 23(1): 30–5.
Gosar D, Ravnik I. Measuring driving performance during EEG events: contribution to individualized counselling on traffic safety in a patient with ring20 chromosome syndrome. Epilepsia. 2009; 50 suppl 10: 141–2.
Krestel HE, Nirkko A, Allmen A, Liechti C, Wettstein J, Mosbacher A, et al. Spike-triggered reaction-time EEG as a possible assessment tool for driving ability. Epilepsia. 2011; 52(10 Suppl): e126–9.
Krankheit und Kraftverkehr. Gutachten des Gemeinsamen Beirats für Verkehrsmedizin beim Bundesminister für Verkehr und beim Bundesminister für Gesundheit. Bonn: Bundesminister für Verkehr; 1992.
Pravilnik o zdravstvenih pogojih, ki jih morajo izpolnjevati vozniki motornih vozil. Ur l SFRJ 5/1982.
Pravilnik o zdravstvenih pogojih voznikov motornih vozil. Ur l 47/2011.
Tiamkao S, Sawanyawisuth K, Towanabut S, Visudhipun P. Seizure attacks while driving: quality of life in persons with epilepsy. Can J Neurol Sci. 2009; 36: 475–9.
No YJ, Lee SJ, Park H, Lee SA. Factors contributing to driving by people with uncontrolled seizures. Seizure. 2011; 20: 491–3.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.